WikiMD's WELLNESSPEDIA
WikiMD's WELLNESSPEDIA
Search
Log in
↓
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Navigation menu
Navigation
Main page
Current events
Recent changes
Popular pages
Random page
Upload file
Special pages
WikiMD St@tistics
Wellness matters
Wellness
Diet
Recipes
Weight loss diet
Encyclopedia
Health encyclopedia
Disease index
Health topics
Glossaries
Rare diseases
Sister projects
Christian Encyclopedia
Sponsors
W8MD weight loss centers
Budget GLP1 shots NYC
Philadelphia medical weight loss
Contact
Contact us
Navigation
Speci@l PageS
Editing
NFE2L2
From WikiMD's WELLNESSPEDIA
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
[[File:Inputs_and_outputs_of_KEAP1_NRF2_pathway.jpg|thumb|Inputs_and_outputs_of_KEAP1_NRF2_pathway.jpg]] '''NFE2L2''' (Nuclear factor erythroid 2-related factor 2) is a [[transcription factor]] encoded by the '''NFE2L2''' gene in humans. It plays a crucial role in the regulation of the expression of antioxidant proteins that protect against oxidative damage triggered by injury and inflammation. == Function == NFE2L2 is a member of the [[Cap 'n' Collar (CNC)]] family of transcription factors. It is primarily involved in the cellular response to oxidative stress. Under normal conditions, NFE2L2 is bound by [[KEAP1]] (Kelch-like ECH-associated protein 1) in the cytoplasm, which targets it for ubiquitination and subsequent degradation by the [[proteasome]]. However, under oxidative stress, NFE2L2 is released from KEAP1, translocates to the [[nucleus]], and binds to the [[Antioxidant Response Element (ARE)]] in the promoter regions of target genes. This binding initiates the transcription of various cytoprotective genes, including those involved in [[glutathione]] synthesis, [[NADPH]] regeneration, and the detoxification of reactive oxygen species (ROS). == Clinical Significance == Mutations and dysregulation of NFE2L2 have been implicated in several diseases, including [[cancer]], [[neurodegenerative diseases]], and [[chronic obstructive pulmonary disease (COPD)]]. Overexpression of NFE2L2 has been observed in various types of cancer, where it contributes to the survival and proliferation of cancer cells by enhancing their antioxidant capacity. Conversely, loss of NFE2L2 function can lead to increased susceptibility to oxidative stress and related pathologies. == Interactions == NFE2L2 interacts with several proteins, including: * [[KEAP1]]: Regulates the stability and activity of NFE2L2. * [[MafG]]: Forms heterodimers with NFE2L2 to bind to ARE. * [[CUL3]]: Part of the E3 ubiquitin ligase complex that targets NFE2L2 for degradation. == Research == Ongoing research is focused on understanding the precise mechanisms of NFE2L2 regulation and its role in disease. Therapeutic strategies aimed at modulating NFE2L2 activity are being explored for the treatment of diseases associated with oxidative stress. == See Also == * [[Oxidative stress]] * [[Transcription factor]] * [[KEAP1]] * [[Antioxidant Response Element (ARE)]] == References == {{Reflist}} == External Links == {{Wikidata|Q14860694}} [[Category:Transcription factors]] [[Category:Human proteins]] [[Category:Antioxidants]] [[Category:Genes on human chromosome 2]] {{Transcription-stub}}
Summary:
Please note that all contributions to WikiMD's WELLNESSPEDIA are considered to be released under the CC By SA 4.0 (see
WikiMD:Copyrights
for details). If you do not want your writing to be edited mercilessly and redistributed at will, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource.
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Templates used on this page:
Template:Reflist
(
edit
)
Template:Transcription-stub
(
edit
)
Template:Wikidata
(
edit
)
Module:Wd
(
edit
)